Sverker Hasselblom
Halmstad, N, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patients.
Journal: Leukemia & lymphoma
Published: June 11, 2021
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study.
Journal: Blood cancer journal
Published: January 24, 2021
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.
Journal: British journal of haematology
Published: July 08, 2020
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.
Journal: American journal of hematology
Published: April 23, 2018
Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients.
Journal: British journal of haematology
Published: November 23, 2017
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.
Journal: Leukemia & lymphoma
Published: February 19, 2016
SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients.
Journal: International journal of proteomics
Published: December 28, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026